EUVIMEDEUVIMED entdecken
Korrektur

Correction to “Mesalamine in Treatment of Intestinal Inflammatory Diseases—Formulation‐Driven Strategies for Targeted Colonic Therapy and Remission Maintenance”

Drug Development Research · 2026-11 · 87 (7)

DOI: 10.1002/ddr.70393 ↗

Kurz gefasst

Korrektur in der Zeitschrift Drug Development Research, online erschienen am 11.10.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Mesalamine in Treatment of Intestinal Inflammatory Diseases—Formulation‐Driven Strategies for Targeted Colonic Therapy and Remission Maintenance”. Drug Development Research, 87(7). https://doi.org/10.1002/ddr.70393

Vancouver

Correction to “Mesalamine in Treatment of Intestinal Inflammatory Diseases—Formulation‐Driven Strategies for Targeted Colonic Therapy and Remission Maintenance”. Drug Development Research. 2026;87(7). doi:10.1002/ddr.70393

BibTeX
@article{euvimed2026,
  title = {Correction to “Mesalamine in Treatment of Intestinal Inflammatory Diseases—Formulation‐Driven Strategies for Targeted Colonic Therapy and Remission Maintenance”},
  journal = {Drug Development Research},
  year = {2026},
  volume = {87},
  number = {7},
  doi = {10.1002/ddr.70393}
}
Kostenlos starten →